30.15 USD
↗ 0.65 (2.20%)AT CLOSE (03:59 PM EDT)
Celldex Therapeutics, Inc
CLDXNASDAQ • USD
30.14
↘ 0.01 (0.03%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
30.14
↘ 0.01 (0.03%)
Market: CLOSED
Shares of Celldex Therapeutics, Inc (CLDX) are trading at $30.14. Our models show a "Neutral" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 27, 2026.
Open?$29.50
High?$30.40
Low?$29.33
Prev. Close?$29.50
Volume?746.6K
Avg. Volume?2.0M
VWAP?$30.03
Rel. Volume?0.38x
Bid / Ask
Bid?$25.55 × 100
Ask?$37.42 × 100
Spread?$11.87
Midpoint?$31.49
Valuation & Ratios
Market Cap?2.3B
Shares Out?78.5M
Float?74.0M
Float %?94.2%
P/E Ratio?N/A
P/B Ratio?3.24
EPS?-$3.83
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Employees
198
Market Cap
2.3B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
1986-05-15
Address
53 FRONTAGE ROAD
HAMPTON, NJ 08827
Phone: 908-200-7500
HAMPTON, NJ 08827
Phone: 908-200-7500
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?16.63Safe
Confidence?55%Low
Short InterestHigh
Short % of Float?12.97%High
Short Interest?9.6M
Days to Cover?5.9
Free Float74.0M
Avg Daily Volume1.6M
Settlement Date2026-10-15
Financial Health
Current Ratio?11.82Strong
Quick Ratio?11.82Strong
Cash Ratio?0.77Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.24FAIR▾
Peers100
S&P52
P/S?14,662.16HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.0CHEAP▾
S&P97
EV/Sales?14,361.82HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-42.1%WEAK▾
S&P3
ROA?-38.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-242105000
Enterprise Value?$2.3B
Fundamentals ratios updated end of day